| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 228.64% | Baird | → $7 | Initiates Coverage On | → Outperform |
| 05/18/2023 | 369.48% | Maxim Group | $8 → $10 | Maintains | Buy |
| 08/03/2021 | 289.67% | Ladenburg Thalmann | → $8.3 | Initiates Coverage On | → Buy |
What is the target price for Immutep (IMMP)?
The latest price target for Immutep (NASDAQ: IMMP) was reported by Baird on August 2, 2023. The analyst firm set a price target for $7.00 expecting IMMP to rise to within 12 months (a possible 228.64% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Immutep (IMMP)?
The latest analyst rating for Immutep (NASDAQ: IMMP) was provided by Baird, and Immutep initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Immutep (IMMP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immutep, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immutep was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
Is the Analyst Rating Immutep (IMMP) correct?
While ratings are subjective and will change, the latest Immutep (IMMP) rating was a initiated with a price target of $0.00 to $7.00. The current price Immutep (IMMP) is trading at is $2.13, which is within the analyst's predicted range.